User profiles for MICHAEL C. JIN
 | Michael C. JinStanford University School of Medicine Verified email at stanford.edu Cited by 2664 |
Integrating genomic features for non-invasive early lung cancer detection
Radiologic screening of high-risk adults reduces lung-cancer-related mortality 1 , 2 ; however,
a small minority of eligible individuals undergo such screening in the United States 3 , 4 . …
a small minority of eligible individuals undergo such screening in the United States 3 , 4 . …
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
Circulating tumor-derived DNA (ctDNA) is an emerging biomarker for many cancers, but the
limited sensitivity of current detection methods reduces its utility for diagnosing minimal …
limited sensitivity of current detection methods reduces its utility for diagnosing minimal …
[HTML][HTML] Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma
Purpose Outcomes for patients with diffuse large B-cell lymphoma remain heterogeneous,
with existing methods failing to consistently predict treatment failure. We examined the …
with existing methods failing to consistently predict treatment failure. We examined the …
[PDF][PDF] Noninvasive early identification of therapeutic benefit from immune checkpoint inhibition
Although treatment of non-small cell lung cancer (NSCLC) with immune checkpoint inhibitors
(ICIs) can produce remarkably durable responses, most patients develop early disease …
(ICIs) can produce remarkably durable responses, most patients develop early disease …
[PDF][PDF] Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas
… Oak,6 Michael C. Jin,1 Sara Beygi,1 Andreas Hüttmann,7 Christine Hanoun,7 Ulrich … (C)
Illustration demonstrating model in which increased fragmentation of tissue-derived DNA occurs …
Illustration demonstrating model in which increased fragmentation of tissue-derived DNA occurs …
[PDF][PDF] Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction
Accurate prediction of long-term outcomes remains a challenge in the care of cancer patients.
Due to the difficulty of serial tumor sampling, previous prediction tools have focused on …
Due to the difficulty of serial tumor sampling, previous prediction tools have focused on …
Pediatric thyroid cancer incidence and mortality trends in the United States, 1973-2013
Importance The incidence of thyroid cancer is increasing by 3% annually. This increase is
often thought to be attributable to overdiagnosis in adults. A previous study reported a 1.1% …
often thought to be attributable to overdiagnosis in adults. A previous study reported a 1.1% …
Circulating tumor DNA profiling for detection, risk stratification, and classification of brain lymphomas
…, S Bleul, M Olsen, CL Liu, MC Jin… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE Clinical outcomes of patients with CNS lymphomas (CNSLs) are remarkably
heterogeneous, yet identification of patients at high risk for treatment failure is challenging. …
heterogeneous, yet identification of patients at high risk for treatment failure is challenging. …
Stem cell therapies for acute spinal cord injury in humans: a review
Recent advances in stem cell biology present significant opportunities to advance clinical
applications of stem cell–based therapies for spinal cord injury (SCI). In this review, the …
applications of stem cell–based therapies for spinal cord injury (SCI). In this review, the …
Short diagnosis-to-treatment interval is associated with higher circulating tumor DNA levels in diffuse large B-cell lymphoma
…, U Dührsen, A Hüttmann, C Schmitz, MC Jin… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Patients with Diffuse Large B-cell Lymphoma (DLBCL) in need of immediate
therapy are largely under-represented in clinical trials. The diagnosis-to-treatment interval (DTI) …
therapy are largely under-represented in clinical trials. The diagnosis-to-treatment interval (DTI) …